Insider holders · CIK 0001018735
NYMOX PHARMACEUTICAL CORP · NYMX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Paul AverbackCEO | 23,331,448 | — | 23,331,448 | Nov 6, 2018 · 5:33 pm EST | Form 4 |
| James George RobinsonDirector | 3,310,550 | 49,550 | 3,360,100 | Dec 14, 2018 · 3:58 pm EST | Form 4 |
| Randall J LanhamGeneral Counsel | 152,900 | — | 152,900 | Nov 6, 2018 · 5:20 pm EST | Form 4 |
| Erik DanielsenCFO | 20,900 | — | 20,900 | Jan 3, 2019 · 1:09 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.